Watchlist Price Alert

Portage Biotech Inc. (PRTG)

NASDAQ: PRTG · Real-Time Price · USD

8.10

-0.15 (-1.82%)

At close: May 23, 2025, 3:59 PM

8.25

1.85%

After-hours: May 23, 2025, 05:06 PM EDT

-1.82% (1D)

Bid	7.56
Market Cap	9.08M
Revenue (ttm)	n/a
Net Income (ttm)	-67.28M
EPS (ttm)	-68.17
PE Ratio (ttm)	-0.12
Forward PE	-0.78
Analyst	n/a

Ask	8.45
Volume	8,374
Avg. Volume (20D)	1,345,677
Open	8.09
Previous Close	8.25
Day's Range	7.78 - 8.22
52-Week Range	2.10 - 23.01
Beta	0.84

About PRTG

undefined

[Read more]

Industry n/a

Sector n/a

IPO Date n/a

Employees NaN

Stock Exchange n/a

Ticker Symbol PRTG

Website n/a

Full Company Profile

Why Price Moved

3 weeks ago

+27.46%

Portage Biotech shares are trading higher after th... Unlock content with Pro Subscription

1 month ago

+103.82%

Portage Biotech shares are trading higher after the company reported new data for PORT-7 at the 2025 European Lung Cancer Congress.

News

3 weeks ago · benzinga.com

Portage Biotech Stock Surges As It Prepares For Human Trial

Portage Biotech's PORT-7 showed >90% tumor growth inhibition with anti-PD1 combo in a murine mesothelioma model. PORT-7 single-agent activity outperformed anti-PD1 treatment alone; first-in-human tria...

1 month ago · benzinga.com

Why Is Portage Biotech Stock Skyrocketing Friday?

Portage Biotech Inc. PRTG on Thursday presented new preclinical data for PORT-7 (TT-4), a selective Adenosine A2B receptor inhibitor, at the 2025 European Lung Cancer Congress.

1 month ago · marketwatch.com

Portage Biotech Shares More Than Double After Results of PORT-7 Tumor Treatment Trial

Portage Biotech have more than doubled in the after-hours market after the company reported preclinical results for PORT-7 in a murine mesothelioma model.